UNIGEF 250 TABLET contains Gefitinib which belongs to the group of medicines called Antineoplastics. It is indicated in adults for the management of locally advanced or metastatic non-small cell lung cancer (NSCLC) who have activating mutation of the EGFR-TK. \r\n\r\nIt is generally characterized by symptoms such as chest pain or discomfort, persistent cough, trouble breathing, wheezing, tiredness and difficulty while swallowing which may be diagnosed as any of its type as adenocarcinoma (cancer involving the outer part of the lung), squamous cell carcinoma (cancer occurring in the centre part of the lungs) and large cell carcinoma (cancer that can occur in any part of the lung).\r\n\r\nAlong with this management, your doctor might ask you to take liver function test to assess your liver function. \r\n\r\nUNIGEF 250 TABLET is not recommended for use in patients who are allergic to Gefitinib. Before taking UNIGEF 250 TABLET, inform your doctor if you have other lung problems, liver or kidney problems.\r\n\r\nUNIGEF 250 TABLET is not recommended for use in pregnant and breastfeeding women. It is not recommended for use in children and adolescents (aged below 18 years). Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\nThe most common side effects of taking UNIGEF 250 TABLET are diarrhoea, vomiting, nausea, skin reactions, loss of appetite, weakness and red or sore mouth. Consult with your doctor if any of the symptoms worsen.\r\n\r\nUses Of UNIGEF 250 TABLET\r\nUsed to manage adults with non-small cell lung cancer\r\nHow UNIGEF 250 TABLET Works\r\nUNIGEF 250 TABLET works by decreasing the survival rate and proliferation of malignant cancer cells in lung tissues by blocking a protein called epidermal growth factor receptor (EGFR) which is responsible for the growth and spread of cancer cell thereby controlling the growth and spread of cancer cells to other parts of the body.\r\n\r\nHow to use UNIGEF 250 TABLET\r\nTake UNIGEF 250 TABLET as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of UNIGEF 250 TABLET for you depending upon your age, body weight and disease condition.\r\n\r\nSide Effects Of UNIGEF 250 TABLET\r\nCommon\r\ndiarrhoea\r\nvomiting\r\nnausea\r\nskin reactions (acne-like rash)\r\nloss of appetite\r\nweakness\r\nred or sore and dry mouth\r\ndry, red or itchy eyes\r\nred and sore eyelids\r\nnail problems\r\nhair loss\r\nfever\r\nbleeding such as nosebleed or blood in urine\r\nsigns of cystitis such as burning sensations while urinating, urgent need to urinate\r\nUncommon\r\nsigns of inflamed pancreas such as very severe pain in the upper part of the abdomen, severe nausea and vomiting\r\nsigns of inflammation of the liver such as general feeling of being unwell, with or without possible jaundice (yellowing of the skin and eyes)\r\nsigns of gastrointestinal perforation such as severe stomach pain, chills, fever\r\nsigns of palmar-plantar erythrodysaesthesia syndrome or hand and foot syndrome such as skin reaction on the palms of the hands and soles of the feet with tingling, numbness, swelling, redness or pain\r\nRare\r\nsigns of inflammation of the blood vessels in the skin such as bruising or patches of non-blanching rash on the skin\r\nsigns of haemorrhagic cystitis (inflammatory condition of urinary bladder) such as burning sensation while urinating, urgent need to urinate along with blood in the urine\r\nStop taking UNIGEF 250 TABLET and contact your doctor immediately if you experience any of the following side effects:\r\n\r\nsigns of allergic reaction such as swollen face, lips, tongue or throat, red and itchy skin, nettle rash and difficulty breathing and difficulty in swallowing\r\nsigns of interstitial lung disease (inflammation and scarring of lung disease) such as serious breathlessness, or sudden worsening of breathlessness possibly with a cough or fever\r\ndehydration due to long term or severe diarrhoea, vomiting, nausea, or loss of appetite\r\nsigns of an ulcer on the surface of the eye (cornea) such as pain, redness, watery eyes, light sensitivity, changes in vision or ingrowing eyelashes\r\nHow To Manage Side Effects\r\n\r\nDiarrhea\r\nDrink lot of fluids, such as water, squash or fruit juice to keep yourself hydrated. Do not take any medicine on your own for managing diarrhea without consulting your doctor.\r\n\r\n\r\nLoss Of Appetite\r\nEat when you feel hungry. Eat smaller meals frequently than usual. Snack only when you\'re hungry. Consult your doctor if the symptom did not improve.\r\n\r\n\r\nNausea And Vomiting\r\nStick to simple meals. Avoid eating oily, fried and spicy foods. Do not perform any strenuous activities immediately after eating. Consult your doctor if the symptom did not improve.\r\n\r\nWarning & Precautions\r\n\r\nPregnancy\r\nContraindicated\r\nUNIGEF 250 TABLET is not recommended for use in pregnant women as it may harm the baby. Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\n\r\nBreastfeeding\r\nContraindicated\r\nUNIGEF 250 TABLET is not recommended for use in breastfeeding women as it is unsafe to the baby. Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\n\r\nDriving and Using Machines\r\nUse with Caution\r\nIf you feel weak while taking UNIGEF 250 TABLET, consult your doctor before driving or using tools or machines.\r\n\r\n\r\nAlcohol\r\nConsult your doctor\r\nAvoid consumption of alcohol while taking UNIGEF 250 TABLET since it may increase the risk of liver damage.\r\n\r\n\r\nKidney\r\nUse with Caution\r\nUNIGEF 250 TABLET should be used with caution in patients having kidney problems. Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\n\r\nLiver\r\nUse with Caution\r\nUNIGEF 250 TABLET should be used with caution in patients having liver problems. Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\n\r\nAllergy\r\nContraindicated\r\nDo not take UNIGEF 250 TABLET if you are allergic to Gefitinib or any other ingredients of this medicine.\r\n\r\n\r\nLungs\r\nUse with Caution\r\nUNIGEF 250 TABLET should be used with caution in patients having other lung disease. Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\n\r\nUse In Pediatrics\r\nContraindicated\r\nUNIGEF 250 TABLET is not recommended for use in children and adolescents (aged below18 years). Consult your child’s doctor for advice before administration of UNIGEF 250 TABLET.\r\n\r\n\r\nUse In Geriatrics\r\nUse with Caution\r\nUNIGEF 250 TABLET should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\nInteractions\r\nA. Drug-Drug Interactions:\r\n\r\nBefore taking UNIGEF 250 TABLET, inform your doctor if you are taking any of the following medicines:\r\n\r\nmedicines used in the management of epilepsy (Ex. phenytoin, carbamazepine)\r\nmedicines used in the management of tuberculosis (Ex. rifampicin)\r\nmedicines used in the management of fungal infection (Ex. itraconazole)\r\nmedicines used in the management of sleeping disorders (Ex. barbiturates such as phenobarbital) \r\nmedicines used to inhibit the formation of blood clots (Ex. warfarin)\r\nmedicines used in the management of ulcers, indigestion, heartburn and to reduce acids in the stomach such as proton-pump inhibitors (Ex. lansoprazole, omeprazole, aluminium hydroxide, magnesium carbonate, cimetidine, famotidine)\r\nSt. John’s wort (herbal remedy used for depression and anxiety)\r\nOverdosage:\r\n\r\nIf you or anyone else accidentally takes too much of UNIGEF 250 TABLET, consult your doctor immediately or visit the nearby hospital.\r\n\r\nSynopsis\r\nDrug : Gefitinib\r\nPharmacological Category : Antineoplastic agents\r\nTherapeutic Indication : Non-small cell lung cancer\r\nDosage Forms : Tablet\r\nMore Information\r\nKeep UNIGEF 250 TABLET out of reach of children\r\nStore at room temperature\r\nFAQs About UNIGEF 250 TABLET\r\nQ: What is UNIGEF 250 TABLET and why is it given?\r\n\r\nA: UNIGEF 250 TABLET contains Gefitinib which belongs to the group of medicines called Antineoplastic agents. It is used in adults to manage non-small cell lung cancer in which malignant cells form in the lung tissue.\r\n\r\nQ: What are the most common side effects of UNIGEF 250 TABLET?\r\n\r\nA: The most common side effects of taking UNIGEF 250 TABLET are diarrhoea, vomiting, nausea, skin reactions, loss of appetite, weakness and red or sore mouth. Consult with your doctor if any of the symptoms worsen.\r\n\r\nQ: Can UNIGEF 250 TABLET be used in children?\r\n\r\nA: No. UNIGEF 250 TABLET is not recommended for use in children and adolescents (aged below 18 years). If UNIGEF 250 TABLET is accidentally ingested by a child or adolescent, go to the hospital immediately and consult the doctor for further management.\r\n\r\nQ: Is UNIGEF 250 TABLET safe for pregnant and breast-feeding women?\r\n\r\nA: UNIGEF 250 TABLET is not recommended for use in pregnant and breast-feeding women since it might cause harm to the foetus and nursing child. Consult your doctor before taking UNIGEF 250 TABLET.\r\n\r\nReferences\r\n1. KD. Tripathi. Anticancer Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 870.\r\n\r\n2. Gefitinib. NIH National Library of Medicine, National center for biotechnology information. Pubchem. [Revised in June 2022] [Accessed on 8th November 2023] https://pubchem.ncbi.nlm.nih.gov/compound/Gefitinib#section=Mechanism-of-Action\r\n\r\n3. Yasoo Sugiura, Etsuo Nemoto, Osamu Kawai,Yasuyuki Ohkubo, Hisae Fusegawa, and Shizuka Kaseda. Gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy. NIH National Library of Medicine, National center for biotechnology information. PMC PubMed Central. June 2013. [Accessed on 8th November 2023] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217440/\r\n\r\n4. Cipla (EU) Limited. Electronic Medicines Compendium (EMC). [Revised in May 2022] [Accessed on 8th November 2023] https://www.medicines.org.uk/emc/files/pil.10456.pdf\r\n\r\n5. AstraZeneca Pharmaceuticals LP Wilmington. U.S. Food & Drug Administration. [Revised in August 2018] [Accessed on 8th November 2023] https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206995s003lbl.pdf\r\n\r\nUseful Diagnostic Tests\r\nLiver function test\r\nCT Scan\r\nPET Scan\r\nComplete Blood Count (CBC)